Clinical metabolomics using stable isotope tracing represents an important new approach to obtaining metabolic parameters in human subjects in situ. In this chapter, the considerations for such clinical metabolomics are outlined and discussed. Descriptions include the essentials of patient accrual, permission, and institutional review approvals as well as specifics of treatments, tissue and biofluid collection, and curation. Although procedures vary among Institutes, the basic features for clinical research are common. Here, we illustrate the process from concept to analysis with an example from a recent study on non-small cell lung cancer metabolomics. This powerful new approach has already provided important new insights into metabolic adaptations in lung cancer cells.

Original languageEnglish
Title of host publicationThe Handbook of Metabolomics
EditorsTeresa Whei-Mei Fan, Richard Higashi, Andrew Lane
Number of pages32
StatePublished - 2012

Publication series

NameMethods in Pharmacology and Toxicology
ISSN (Print)1557-2153
ISSN (Electronic)1940-6053

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • Pharmacology (medical)
  • Molecular Medicine


Dive into the research topics of 'Clinical aspects of metabolomics'. Together they form a unique fingerprint.

Cite this